Creation of the Master Mekong Pharma<\/h1>\n\u2014 Cambodia, Laos, Vietnam \u2014<\/span><\/em><\/h3>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>BACKGROUND<\/h1>\n
Public health indicators in Vietnam, having become more open and established itself as a dynamic emerging country since the 1980s, are showing consistent improvement. With a fledgling but growing pharmaceutical industry and already providing platforms for high-level training, the country seemed to be a good base for Fondation Pierre Fabre when it decided to create a transregional Master\u2019s in Pharmaceutical Sciences programme in the 2010s.<\/p>\n
Pursuing the work already done in Phnom Penh and\u00a0Vientiane<\/a>\u00a0to upgrade their universities of pharmacy, this post-graduate programme known as\u00a0Master Mekong Pharma<\/strong>\u00a0is meant to increase the number of drug experts in Southeast Asia<\/strong>. It is mainly designed for qualified pharmacists in Laos, Cambodia and Vietnam, and allows them to earn a French Master\u2019s 2 degree.<\/p>\nThe project was an exciting one, but complex to develop, particularly since the French diploma was being transferred to Southeast Asia. After designing the overall plan, Fondation Pierre Fabre had to convince the region\u2019s three universities, as well as three other French universities, to assign volunteer teachers to the cause. The Foundation has also been involved in financing the Master and day-to-day coordination in the field. It will provide support until 2016.<\/p>\n
In 2012, the first class was recruited. The students underwent general education in the first year before specialising, in their second year, in drug quality control (in Hanoi), pharmacokinetic (in Phnom Penh), or correct use of medicines and pharmacovigilance (in Vientiane). This class graduated in October 2014.<\/p>\n
The Master Mekong Pharma is meant to serve as a springboard for healthcare South East Asia. The opportunities presented to future graduates will be the proof of its success: they should be able to\u00a0increase the quality of local higher education<\/strong>, improve the hospital care sector, contribute to the work of public structures, such as drug agencies, but also support the private sector that has great needs in Southeast Asia.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>KEY FACTS<\/span><\/strong><\/span>
\n_____<\/span><\/p>\nPriority<\/strong><\/span>
\nTraining of drugs specialists<\/span><\/p>\nProgramme<\/strong><\/span>
\nSince 2010<\/span><\/p>\nType of involvement<\/strong><\/span>
\nDistributor and operator<\/span><\/p>\nActions<\/strong><\/span><\/p>\n\n- Project creation<\/span><\/li>\n
- Funding during the first three Master\u2019s classes (teaching assignments, scholarships)<\/span><\/li>\n
- Coordination (the Foundation\u2019s coordination manager is based in Asia)<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
Hanoi University of Pharmacy<\/strong><\/span>
\n13-15 Le Thanh Tong, Hoan Kiem
\nHANOI
\nVIETNAM
\nwww.hup.edu.vn<\/a>
\nMaster Internet website<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Call for applications for year 2016\/2017<\/h3>\n<\/div>Find\u00a0here\u00a0<\/a>the Master Mekong Pharma 2016 leaflet.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>![](\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27300%27%20height%3D%27230%27%20viewBox%3D%270%200%20300%20230%27%3E%3Crect%20width%3D%27300%27%20height%3D%27230%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\")
<\/div><\/div><\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/Sans-titre-1-1.png\")
<\/p>\n
The current version of the French studies model was not applicable. The Master Mekong Pharma had to be tailored to the circumstances. First, with regard to access \u2013 the first year gives students the knowledge base needed to enter level M2 at French universities. Then, with regard to the programme \u2013 the curriculum was modified to integrate certain specificities, such as local regulatory issues.”<\/span><\/p>\nDr Hanh Dufat
\n<\/span><\/strong>Laboratory for Pharmacognosis-UMR\/CNRS 8638, Faculty of pharmaceutical and biological sciences, University of Paris Descartes<\/span><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>ACHIEVEMENTS AND FUTURE INITIATIVES<\/h2>\n<\/div><\/div><\/div><\/div>Achievements<\/span><\/h4>\n<\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/les_jeunes_diplomes_promotion_3_master_mekong_pharma-2.jpg\")
<\/p>\n
30<\/span>
\n<\/span>first-year students graduated<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/etudiantes_du_m1.jpg\")
<\/p>\n
31<\/span>
\n<\/span>students in training in 2014 (2nd and 3rd classes)
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/monsieur_alain_bousquet_melou_ue_3.jpg\")
<\/p>\n
34<\/span><\/span><\/strong><\/p>\nteaching assignments<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/enseignement_de_monsieur_etienne_chatelut_ue_4.jpg\")
<\/p>\n
1 352<\/span>
\n<\/span>hours of courses taught in 2014
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/faculteu_de_pharmacie_de_phnom_penh.jpg\")
<\/p>\n
80%<\/span>
\n<\/span>of the funding provided by Fondation Pierre Fabre
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/07\/medicaments-master-mekong-pharma-fondation-fabre_0_0.jpg\")
<\/p>\n
66%<\/span>
\n<\/span>of students chose a public-sector internship to conclude their training
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>Future initiatives<\/h3>\n<\/div>In 2015, Fondation Pierre Fabre has supported continuation of the programme with the recruitment of a fourth class in October. Furthermore, the option of opening the training to students from neighbouring countries (China, Burma, Thailand, etc.) is under consideration, as well as introducing a new speciality, pharmaceutical technology, in 2016.<\/p>\n<\/div>
<\/div><\/div><\/div><\/div><\/div>PARTNERS<\/h2>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n- Agence <\/a>universitaire de la francophonie \u2013 AUF\u00a0(funding for teaching assignments and scholarships)<\/li>\n
- Coop\u00e9ration fran\u00e7aise\u00a0<\/a>(funding of French classes)<\/li>\n
- Phnom Penh faculty of pharmacy, (consulting, teaching on pharmacokinetics)<\/li>\n
- Vientiane faculty of pharmacy (consulting, teaching on proper drug use and pharmacovigilance)<\/li>\n
- Hanoi University of Pharmacy\u00a0<\/a>(consulting, teaching on medicine quality control)<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div>
\n- Facult\u00e9 de Pharmacie – Aix-Marseille Universit\u00e9<\/a>\u00a0\u00a0(consulting, teaching on pharmacokinetics)<\/li>\n
- Facult\u00e9 des Sciences Pharmaceutiques et Biologiques – Universit\u00e9 Paris Descartes\u00a0<\/a>\u00a0(consulting, teaching on medicine quality control)<\/li>\n
- Facult\u00e9 des Sciences Pharmaceutiques – Universit\u00e9 Paul Sabatier Toulouse III<\/a>\u00a0\u00a0(consulting, teaching on proper drug use and pharmacovigilance)<\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div><\/div>
See also<\/span><\/h4>\n<\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
BACKGROUND<\/h1>\n
Public health indicators in Vietnam, having become more open and established itself as a dynamic emerging country since the 1980s, are showing consistent improvement. With a fledgling but growing pharmaceutical industry and already providing platforms for high-level training, the country seemed to be a good base for Fondation Pierre Fabre when it decided to create a transregional Master\u2019s in Pharmaceutical Sciences programme in the 2010s.<\/p>\n
Pursuing the work already done in Phnom Penh and\u00a0Vientiane<\/a>\u00a0to upgrade their universities of pharmacy, this post-graduate programme known as\u00a0Master Mekong Pharma<\/strong>\u00a0is meant to increase the number of drug experts in Southeast Asia<\/strong>. It is mainly designed for qualified pharmacists in Laos, Cambodia and Vietnam, and allows them to earn a French Master\u2019s 2 degree.<\/p>\n The project was an exciting one, but complex to develop, particularly since the French diploma was being transferred to Southeast Asia. After designing the overall plan, Fondation Pierre Fabre had to convince the region\u2019s three universities, as well as three other French universities, to assign volunteer teachers to the cause. The Foundation has also been involved in financing the Master and day-to-day coordination in the field. It will provide support until 2016.<\/p>\n In 2012, the first class was recruited. The students underwent general education in the first year before specialising, in their second year, in drug quality control (in Hanoi), pharmacokinetic (in Phnom Penh), or correct use of medicines and pharmacovigilance (in Vientiane). This class graduated in October 2014.<\/p>\n The Master Mekong Pharma is meant to serve as a springboard for healthcare South East Asia. The opportunities presented to future graduates will be the proof of its success: they should be able to\u00a0increase the quality of local higher education<\/strong>, improve the hospital care sector, contribute to the work of public structures, such as drug agencies, but also support the private sector that has great needs in Southeast Asia.<\/p>\n<\/div> KEY FACTS<\/span><\/strong><\/span> Priority<\/strong><\/span> Programme<\/strong><\/span> Type of involvement<\/strong><\/span> Actions<\/strong><\/span><\/p>\n Hanoi University of Pharmacy<\/strong><\/span> Find\u00a0here\u00a0<\/a>the Master Mekong Pharma 2016 leaflet.<\/p>\n<\/div> The current version of the French studies model was not applicable. The Master Mekong Pharma had to be tailored to the circumstances. First, with regard to access \u2013 the first year gives students the knowledge base needed to enter level M2 at French universities. Then, with regard to the programme \u2013 the curriculum was modified to integrate certain specificities, such as local regulatory issues.”<\/span><\/p>\n Dr Hanh Dufat 30<\/span> 31<\/span> 34<\/span><\/span><\/strong><\/p>\n teaching assignments<\/strong><\/p>\n<\/div> 1 352<\/span> 80%<\/span> 66%<\/span> In 2015, Fondation Pierre Fabre has supported continuation of the programme with the recruitment of a fourth class in October. Furthermore, the option of opening the training to students from neighbouring countries (China, Burma, Thailand, etc.) is under consideration, as well as introducing a new speciality, pharmaceutical technology, in 2016.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
\n_____<\/span><\/p>\n
\nTraining of drugs specialists<\/span><\/p>\n
\nSince 2010<\/span><\/p>\n
\nDistributor and operator<\/span><\/p>\n\n
<\/div><\/div><\/div><\/div><\/div><\/div><\/div>
\n13-15 Le Thanh Tong, Hoan Kiem
\nHANOI
\nVIETNAM
\nwww.hup.edu.vn<\/a>
\nMaster Internet website<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Call for applications for year 2016\/2017<\/h3>\n<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n
\n<\/span><\/strong>Laboratory for Pharmacognosis-UMR\/CNRS 8638, Faculty of pharmaceutical and biological sciences, University of Paris Descartes<\/span><\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>ACHIEVEMENTS AND FUTURE INITIATIVES<\/h2>\n<\/div>
<\/div><\/div><\/div>Achievements<\/span><\/h4>\n<\/div>
<\/div><\/div><\/div><\/p>\n
\n<\/span>first-year students graduated<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n
\n<\/span>students in training in 2014 (2nd and 3rd classes)
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n
\n<\/span>hours of courses taught in 2014
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/p>\n
\n<\/span>of the funding provided by Fondation Pierre Fabre
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/p>\n
\n<\/span>of students chose a public-sector internship to conclude their training
\n<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>Future initiatives<\/h3>\n<\/div>
<\/div><\/div><\/div><\/div><\/div>PARTNERS<\/h2>\n<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>\n
<\/div><\/div><\/div>\n
<\/div><\/div><\/div><\/div><\/div>See also<\/span><\/h4>\n<\/div>
![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/09\/medicaments-laos-fondation-fabre.jpg\")
<\/a><\/li><\/div>![\"\"](\"https:\/\/dev.fondationpierrefabre.org\/wp-content\/uploads\/2018\/09\/medicaments-benin-fondation-fabre_0.jpg\")
<\/a><\/li><\/div>